Panel Discussion: Understanding What Makes an AgBiotech Company Worth Buying to Attract Investment, Secure Strategic Partnerships & Accelerate Growth

3:30 pm - Thursday 1st April 2027

  • Examine the technologies and capabilities attracting attention from global agribusinesses and investors, revealing what buyers are willing to pay a premium for, to build a more competitive and differentiated business.
  • Understand how strategic partners assess scalability, product performance, regulatory readiness, and commercial potential, uncovering the key indicators of long-term success, to increase your attractiveness to investors and acquirers.
  • Benchmark your company’s maturity against recent deals and collaborations in biologicals and microbiome innovation, identifying potential gaps and value drivers, to accelerate your path toward partnership, investment, or acquisition.

Speakers:

Head of Byrne Advisory
Byrne & Co
Director of Biologicals, Americas
Yara International
Venture Partner
LeVert Ventures